semaglutide arrhythmia Frontiers Semaglutide and the Heart: Focus

The molecular structure of semaglutide differs significantly from the naturally occurring GLP-1 hormone, with modifications including amino acid substitutions and the addition of a fatty acid side chain that allows binding to albumin, thereby extending its half-life from minutes to approximately one week

Noninferiority endpoint not met

It calls shared decision-making, informed consent, and documented conversations about risks, benefits and alternatives essential components of responsible reproductive care

Improved affordability and local production initiatives accelerate GLP-1 drugs adoption in the region

Cautions It is not suitable during pregnancy It is not suitable during breastfeeding Storage Keep the product in a dry, cool place up to 25C (77F), and protect it from light